| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |